Posted in | News | Graphene

Cientifica PLC Enters Into a Collaboration with Perpetuus Carbon Group

Cientifica PLC, the AIM listed company focused on applications of graphene, has entered into a collaboration with Perpetuus Carbon Group ("Perpetuus"), a world leader in the production of nano surface modified graphenes.

Cientifica is focusing on investment in a number of specific areas ranging from energy efficiency to health, with the aim of bringing a number of significant applications enabled by graphene to market in the near term.

The objective of the collaboration is to bring together technology, market demand and finance, with a view to placing the UK at the forefront of the commercialisation of graphene. It also creates an integrated value chain spanning graphene production to consumer and industrial applications.

Perpetuus will provide technical support to Cientifica's planned product development with the aim of reducing the time to market by combining the technical and market expertise of both companies. A number of graphene-enabled products, including infrared heating technology will be on display at the 2nd Annual Graphene Supply, Application and Commercialisation Conference in Manchester, 13 June 2014.

The patented infrared heating technology on display, involving flat panel heaters makes use of graphene to emit infrared light at wave-lengths precisely tailored for maximum comfort and minimum energy use. The graphene enabled technology allows users to maintain the same levels of comfort, whilst using up to 70% less energy than conventional heaters.

Perpetuus supplies graphenes that have been produced in a dry, environmentally friendly manner, unlike many other graphene suppliers who use acids and surfactants, which leaves behind toxic by-products. Perpetuus' proprietary technology allows it to populate a variety of chemical groups onto and within the nano structure of graphenes to a customer's precise specification and deliver in kilos and tonnes.

Tim Harper, CEO of Cientifica PLC, explained:

"We are focused on a number of specific areas and have identified a number of graphene-enabled applications where, as products move from prototype to market we need a partner that can supply us and our future partners material in a ready for use form, and in significant quantities to meet customer demand. We needed to find a company that can supply tonnes rather than grams per week, of consistent quality materials at competitive prices.

"By partnering with Perpetuus we believe we will be able to quickly incorporate the appropriate functionalised graphene material into our future products which we believe will allow us to significantly bring forward the launch of a number of products."

Ian Walters of Perpetuus commented:

"Many of the proposed applications of graphene are long term, and taking products to market over such long timescales can be challenging. Cientifica's focus on identifying near term real-world applications of graphene, backed with intellectual property will help to create a quickly expanding market for Perpetuus' applications and products."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cientifica Ltd. (2019, February 11). Cientifica PLC Enters Into a Collaboration with Perpetuus Carbon Group. AZoNano. Retrieved on April 19, 2024 from https://www.azonano.com/news.aspx?newsID=30377.

  • MLA

    Cientifica Ltd. "Cientifica PLC Enters Into a Collaboration with Perpetuus Carbon Group". AZoNano. 19 April 2024. <https://www.azonano.com/news.aspx?newsID=30377>.

  • Chicago

    Cientifica Ltd. "Cientifica PLC Enters Into a Collaboration with Perpetuus Carbon Group". AZoNano. https://www.azonano.com/news.aspx?newsID=30377. (accessed April 19, 2024).

  • Harvard

    Cientifica Ltd. 2019. Cientifica PLC Enters Into a Collaboration with Perpetuus Carbon Group. AZoNano, viewed 19 April 2024, https://www.azonano.com/news.aspx?newsID=30377.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.